Imunon, Inc. — Director's Dealing 2014

Mar 14, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Celsion CORP (CLSN)
CIK: 0000749647
Period of Report: 2014-03-14

Reporting Person: Tardugno Michael H (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-03-14	Celsion Corporation Common Stock	P	4000	$3.84	Acquired	57521	Direct

Footnotes

F1: The Officer purchased the shares on the open market.